NCT04372576

Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 30 (estimated)
• Sponsor: Semmelweis University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to determine the risk factors for development of ventilator-associated pneumonia (VAP) and to identify the prognostic factors of VAP among Coronavirus Disease 2019 (CoViD-19) patients. We hypothesized that CoViD-19 serves as a high risk factor for the development of VAP and it affects clinical outcome measures negatively.

Detailed description

Coronavirus Disease 2019 (CoViD-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a pandemic affecting thousands of individuals worldwide. A considerable proportion of CoViD-19 patients require admission to the intensive care unit (ICU), although limited data are available on their clinical characteristics and course. The results of retrospective studies indicate older age, presence of comorbidies and secondary infections as predictors of mortality among this population. Further evaluation regarding ICU clinical course and predictors of mortality is needed. The aim of this study is to determine the risk factors for development of VAP and to identify the prognostic factors of VAP among CoViD-19 patients.

Conditions

• Ventilator Associated Pneumonia
• Corona Virus Infection

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Assessment of ventilator-associated pneumonia criteria	Diagnosis of ventilator-associated pneumonia is based upon the routine daily clinical and laboratory parameters.

Timeline

• Start date: 2020-04-16
• Primary completion: 2020-08-01
• Completion: 2020-08-01
• First posted: 2020-05-04
• Last updated: 2020-05-04

Locations

1 site across 1 country: Hungary